MEN1 and Down syndrome: Women with the MEN1 syndrome showed an increased risk of breast cancer occurrence, and heterozygous MEN1 deletion or loss of menin expression were observed in breast cancer cells of MEN1 patients [17], indicating the tumor suppression function of menin in breast tumorigenesis.